During the past decades, a great bulk of studies have been undertaken to investigate the pathophysiologic mechanisms responsible for thrombus formation. As a consequence, different therapeutic strategies interfering at different levels of the coagulation process have been developed. Many of these compounds did not achieve full development, but others are presently available for the clinician. The present review paper will focus on these new therapeutic strategies developed in the last 10 years.
[New antithrombotic drugs in cardiovascular disease] / P., Golino; G., Cimmino; I., Porchetta; M., Spadera; Volpe, Massimo; R., Calabro. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1827-6806. - 7:2(2006), pp. 109-118.
[New antithrombotic drugs in cardiovascular disease].
VOLPE, Massimo;
2006
Abstract
During the past decades, a great bulk of studies have been undertaken to investigate the pathophysiologic mechanisms responsible for thrombus formation. As a consequence, different therapeutic strategies interfering at different levels of the coagulation process have been developed. Many of these compounds did not achieve full development, but others are presently available for the clinician. The present review paper will focus on these new therapeutic strategies developed in the last 10 years.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
